PharmaPrint
This article was originally published in The Tan Sheet
Executive Summary
Nutraceutical developer issued U.S. patent covering the PharmaPrint standardization process for St. John's wort, as well as an Australian patent applicable to the PharmaPrint process for all botanicals. A U.S. patent on PharmaPrint technology for saw palmetto was issued in March. The Newport Beach, Calif.-based firm also announces settlement of litigation with American Home Products over alleged breaches of licensing and supply agreements for Centrum Herbals (1"The Tan Sheet" Nov. 29, 1999, p. 9). Under the confidential settlement, PharmaPrint will continue to produce its own products and pursue its patents, while AHP will continue to produce its own dietary supplements
You may also be interested in...
Centrum Herbals Supply Terms, Technology Contested By AHP, PharmaPrint
American Home Products and PharmaPrint are suing each other over alleged breaches of license and supply agreements for Centrum Herbals. PharmaPrint additionally is charging AHP with using PharmaPrint's technology to create its own line of combination products containing an herbal and one vitamin, mineral and/or other nutrient, to be launched within six months.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands